Anavex Life Sciences Provides Clinical Programs Update and Reports Fiscal First Quarter 2018 Financial Results
Anavex Life Sciences to Announce Fiscal First Quarter 2018 Financial Results and Provide an Update on Clinical Programs and Corporate Highlights on Wednesday, February 7, 2018
Anavex Life Sciences to Present at the Noble Capital Markets 14th Annual Institutional Investor Conference
San Francisco, January 8th through 11th at the J.P. Morgan Healthcare Conference. Anavex is attending the 36th annual J.P. Morgan Healthcare Conference, the largest and most informative healthcare investment symposium in the industry.
Anavex Life Sciences Reports Fiscal 2017 Financial Results And Provides Update On Therapeutic Programs
Efficacy of ANAVEX 2-73, a Sigma-1 receptor agonist, in the MECP2 mouse model of Rett syndrome
Anavex Life Sciences will be presenting data at the CTAD conference in Boston, Massachusetts on Saturday November 4th at 3:30 PM.
Anavex Life Sciences Announces New Data Related to Multiple Sclerosis Presented at 7th ECTRIMS-ACTRIMS Meeting MSPARIS2017
Anavex Life Sciences will be presenting at 11am this year at the OktoberINVESTfest. The day long event will be held at the New York Academy of Sciences on 250 Greenwich Street in New York City from 8am to 6pm.